Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 86 (RPL21P86)

Target
RPL21P86
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 86 (RPL21P86) is a non-functional genomic sequence derived from the ribosomal protein L21 gene. Pseudogenes like RPL21P86 do not encode functional proteins and are generally considered evolutionary remnants without direct biological roles. However, a minority of pseudogenes can be transcribed as non-coding RNAs and participate in gene regulation, typically through mechanisms like mRNA stability modulation, antisense transcription, or as microRNA decoys, but no specific regulatory function is documented for RPL21P86 itself[1][6][7]. The parent gene, RPL21, encodes a structural component of the 60S large ribosomal subunit and is essential in protein synthesis, but RPL21P86 is distinct from and does not perform this role[1][3][5]. RPL21P86 is annotated in databases, such as GeneCards, BioGPS, and the GWAS Catalog, as a pseudogene located on chromosome 9q22.31[1][6][8]. There are no known therapeutic applications, disease associations, or interacting drugs for this pseudogene[1][5][8]. In summary, RPL21P86 is a processed pseudogene, not a therapeutic target, and is not associated with any established physiological or pathological roles.

Other names
RPL21_34_998RPL21P86
02

Mechanism of action

Not applicable; there are no drugs targeting this pseudogene.

03

Biological functions

Generally none as a protein; pseudogenes may occasionally be transcribed as non-coding RNAs with regulatory roles but no direct protein function for RPL21P86 is described
04

Disease associations

None known for RPL21P86 itself. The functional RPL21 gene is associated with hypotrichosis simplex, but roles for this pseudogene in disease are not established
05

Safety considerations

Not applicable, as this is not a therapeutic target
06

Interacting drugs

None known; no drugs are indicated to interact with RPL21P86
07

Biomarkers

None known for RPL21P86

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 86 (RPL21P86).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 86 (RPL21P86).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call